You are here:
etoricoxib (Arcoxia)
Advice
In the absence of a submission from the holder of the marketing authorisation:
etoricoxib (Arcoxia®) is not recommended for use within NHS Scotland.
Indication under review: Short-term treatment of moderate pain associated with dental surgery.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Drug Details
| Drug Name: | etoricoxib (Arcoxia) |
|---|---|
| SMC Drug ID: | 847/12 |
| Manufacturer: | Merck Sharp and Dohme Ltd |
| Indication: | Short-term treatment of moderate pain associated with dental surgery. |
| BNF Category: | |
| Sub Category: | 10.1 Drugs used in rheumatic diseases and gout |
| Submission Type: | Non submission |
| Status: | Not Recommended |
| Date Advice Published: | 14 January 2013 |